Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 43 (C.D.Cal. May. 2, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 43 (C.D.Cal. May. 2, 2023)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 55 (S.D.Ind. Sep. 24, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 55 (S.D.Ind. Sep. 24, 2024)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 48 (S.D.Ind. Sep. 5, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 48 (S.D.Ind. Sep. 5, 2024)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 49 (S.D.Ind. Sep. 5, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 49 (S.D.Ind. Sep. 5, 2024)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 47 (S.D.Ind. Sep. 5, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 47 (S.D.Ind. Sep. 5, 2024)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 45 (S.D.Ind. Sep. 3, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 45 (S.D.Ind. Sep. 3, 2024)
+ More Snippets
Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 44 (S.D.Ind. Sep. 3, 2024)
Cite Document
ENDOCYTE, INC. et al v. POINT BIOPHARMA GLOBAL INC. et al, 1:24-cv-01011, No. 44 (S.D.Ind. Sep. 3, 2024)
+ More Snippets
Docket
1:15-cv-10800,
Illinois Northern District Court
(Dec. 1, 2015)
Matthew F. Kennelly,
presiding.
Cite Docket
Clark v. Eli Lilly and Co. et al, 1:15-cv-10800 (N.D.Ill.)
+ More Snippets
Document
INCRETIN-BASED THERAPY CASES, JCCP4574, Order Appointing Court Approved Reporter (Los Angeles Sup. Ct Nov. 21, 2022)
Cite Document
INCRETIN-BASED THERAPY CASES, JCCP4574, Order Appointing Court Approved Reporter (Los Angeles Sup. Ct Nov. 21, 2022)
+ More Snippets
Document
INCRETIN-BASED THERAPY CASES, JCCP4574, Order Appointing Court Approved Reporter (Los Angeles Sup. Ct Nov. 21, 2022)
Cite Document
INCRETIN-BASED THERAPY CASES, JCCP4574, Order Appointing Court Approved Reporter (Los Angeles Sup. Ct Nov. 21, 2022)
+ More Snippets
Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 98 (C.D.Cal. Sep. 26, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 98 (C.D.Cal. Sep. 26, 2023)
+ More Snippets
Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 96 (C.D.Cal. Sep. 26, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 96 (C.D.Cal. Sep. 26, 2023)
+ More Snippets
Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 93 (C.D.Cal. Sep. 26, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 93 (C.D.Cal. Sep. 26, 2023)
+ More Snippets
Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 39 (C.D.Cal. Feb. 28, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 39 (C.D.Cal. Feb. 28, 2023)
+ More Snippets
Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 128 (C.D.Cal. Dec. 22, 2023)
Cite Document
United States of America et al v. AbbVie Inc. et al, 2:21-cv-04249, No. 128 (C.D.Cal. Dec. 22, 2023)
+ More Snippets